702 Efficacy and Safety of Delayed-Release Oral mesalamine...

Gastroenterology 2008 Vol. 134; Iss. 4-supp-S1

702 Efficacy and Safety of Delayed-Release Oral mesalamine At 4.8g/D (800mg Tablet) in the Treatment of Moderately Active Ulcerative Colitis: Results of the Ascend III Study

William J. Sandborn, Jaroslaw Regula, Brian Feagan, Elena A. Belousova, Njegica V. Jojic, Milan -. Lukas, Bruce R. Yacyshyn, Piotr Krzeski, Chyon-Hwa Yeh, Stephen B. Hanauer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
134
Year:
2008
Language:
english
DOI:
10.1016/s0016-5085(08)60464-3
File:
PDF, 94 KB
english, 2008
Conversion to is in progress
Conversion to is failed